Cullinan Therapeutics News

Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo

Seeking AlphaMay 25 10:24 ET

Cullinan Therapeutics to Participate in Fireside Chat at TD Cowen 5th Annual Oncology Innovation Summit

CAMBRIDGE, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (NASDAQ:CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that Nadim Ahmed,

GlobeNewswireMay 24 08:00 ET

H.C. Wainwright Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $28

H.C. Wainwright analyst Edward White maintains $Cullinan Therapeutics(CGEM.US)$ with a buy rating, and maintains the target price at $28.According to TipRanks data, the analyst has a success rate of 3

moomoo NewsMay 24 06:35 ET

Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combination With a Checkpoint Inhibitor and Updated Monotherapy Data at ASCO 2024

Preliminary data from CLN-619 in combination with checkpoint inhibitor pembrolizumab show objective responses in patients with tumor types that are typically unresponsive to pembrolizumab, such as non-small cell lung

GlobeNewswireMay 23 17:04 ET

Express News | Cullinan Therapeutics Files For Resale Of Up To 14.4M Shares By The Selling Stockholders

BenzingaMay 16 16:45 ET

Express News | Cullinan Therapeutics Inc Files for Resale of up to 14.4 Mln Shares by the Selling Stockholders - SEC Filing

ReutersMay 16 16:12 ET

Express News | Cullinan Therapeutics Shares Are Trading Lower After the Company Reported Q1 Results and Provided a Corporate Update

BenzingaMay 16 15:20 ET

HC Wainwright Adjusts Price Target on Cullinan Oncology to $28 From $29, Maintains Buy Rating

Cullinan Oncology (CGEM) has an average buy rating and a price target range of $28 to $40, according to analysts polled by Capital IQ. Price: 25.23, Change: -1.49, Percent Change: -5.58

MT NewswiresMay 16 12:03 ET

Cullinan Oncology Is Maintained at Buy by HC Wainwright & Co.

Cullinan Oncology Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMay 16 12:00 ET

Express News | Wedbush Reiterates Outperform on Cullinan Therapeutics, Maintains $36 Price Target

BenzingaMay 16 08:22 ET

Express News | Cullinan Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $28 From $29

ReutersMay 16 06:00 ET

Cullinan Therapeutics | 10-Q: Quarterly report

SEC announcementMay 15 22:44 ET · Announcements

Express News | Cullinan Therapeutics Inc: Qtrly Shr Loss $0.86

ReutersMay 15 16:09 ET

Express News | Cullinan Therapeutics: Cash & Investments as of March 31, Plus Gross Proceeds of $280 Mln From April Private Placement Extends Cash Runway Into 2028

ReutersMay 15 16:08 ET

Cullinan Therapeutics 1Q Loss/Shr 86c >CGEM

Cullinan Therapeutics 1Q Loss/Shr 86c >CGEM

Dow JonesMay 15 16:06 ET

Express News | Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

ReutersMay 15 16:05 ET

Press Release: Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results Combination and monotherapy solid tumor dose escalation data for CLN-619 to be presented in a poster s

Dow JonesMay 15 16:05 ET

Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing

Jennifer Michaelson, Chief Scientific Officer, on May 06, 2024, sold 63,606 shares in Cullinan Therapeutics (CGEM) for $1,796,676. Following the Form 4 filing with the SEC, Michaelson has control over

MT NewswiresMay 9 03:20 ET

Insider Sale at Cullinan Therapeutics Inc (CGEM): Chief Scientific Officer Jennifer Michaelson ...

Yahoo FinanceMay 9 03:09 ET

Cullinan Therapeutics(CGEM.US) Officer Sells US$1.8 Million in Common Stock

$Cullinan Therapeutics(CGEM.US)$ Officer Michaelson Jennifer sold 63,606 shares of common stock on May 6, 7, 2024 at an average price of $28.25 for a total value of $1.8 million.Source: Announcement W

moomoo NewsMay 8 20:13 ET